Skip navigation
Products & Support

Multi-Lineage Progenitor Cell™ (MLPC®)

The first commercially available, human umbilical cord blood-derived, clonal, multipotent stem cell line. For research use only.

Approximate Age of Stem Cells - Timeline

Multi-Lineage Progenitor Cell (MLPC®) clonal cell lines are karyotypically normal, multipotent progenitor cells obtained from post-partum human umbilical cord blood, which have been expanded from a single cell. The MLPC has been analyzed for gene expression and has been shown to be a very early progenitor cell capable of extensive differentiation. 

Benefits of the MLPC

  • Readily available inventory
  • Clonal - highly repeatable experimentation
  • Umbilical cord blood source - no ethical controversy
  • Genetically normal and stable - not immortalized
  • Highly characterized and multipotent
  • Robust expansion capabilities without differentiating or losing "stem-ness" qualities

Potential MLPC Applications

  • Alternative to primary tissue culture
  • Disease modeling
  • In vitro toxicology models
  • Compound screening
  • Regenerative medicine / cellular therapy
  • Humanized animal models
  • Studying developmental pathways